Butterfly Network has raised $605.6 million across multiple rounds, beginning with early seed funding in 2011 and expanding through a $100M venture round in 2014, a major $250M Series D in 2018 valuing the company at $1.25B, and a $175M Post-IPO round in 2021. Additional capital came from a $5M Gates Foundation grant in 2022 and $75.6M Post-IPO funding in 2025. Backed by investors like Fidelity, Tenet Healthcare, and Fosun Pharma, Butterfly Network’s Ultrasound-on-Chip™ innovation helped it scale into a global, publicly traded medical imaging leader.